annual CFO:
$11.86B+$1.52B(+14.65%)Summary
- As of today (August 21, 2025), AZN annual cash flow from operations is $11.86 billion, with the most recent change of +$1.52 billion (+14.65%) on December 31, 2024.
- During the last 3 years, AZN annual CFO has risen by +$5.90 billion (+98.91%).
- AZN annual CFO is now at all-time high.
Performance
AZN Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$3.51B-$270.88M(-7.17%)Summary
- As of today (August 21, 2025), AZN quarterly cash flow from operations is $3.51 billion, with the most recent change of -$270.88 million (-7.17%) on June 30, 2025.
- Over the past year, AZN quarterly CFO has increased by +$311.12 million (+9.73%).
- AZN quarterly CFO is now -13.26% below its all-time high of $4.05 billion, reached on December 31, 2009.
Performance
AZN quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$13.72B+$311.12M(+2.32%)Summary
- As of today (August 21, 2025), AZN TTM cash flow from operations is $13.72 billion, with the most recent change of +$311.12 million (+2.32%) on June 30, 2025.
- Over the past year, AZN TTM CFO has increased by +$2.29 billion (+20.06%).
- AZN TTM CFO is now at all-time high.
Performance
AZN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AZN Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +14.7% | +9.7% | +20.1% |
3 y3 years | +98.9% | +179.6% | +79.7% |
5 y5 years | +299.5% | +234.5% | +266.1% |
AZN Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +98.9% | -7.2% | +179.6% | at high | +79.7% |
5 y | 5-year | at high | +299.5% | -7.2% | +292.1% | at high | +266.1% |
alltime | all time | at high | +5650.2% | -13.3% | +455.6% | at high | +2952.0% |
AZN Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $3.51B(-7.2%) | $13.72B(+2.3%) |
Mar 2025 | - | $3.78B(+27.3%) | $13.40B(+9.8%) |
Dec 2024 | $11.86B(+14.7%) | $2.97B(-14.1%) | $12.20B(+4.4%) |
Sep 2024 | - | $3.46B(+8.1%) | $11.69B(+2.4%) |
Jun 2024 | - | $3.20B(+24.0%) | $11.42B(+14.1%) |
Mar 2024 | - | $2.58B(+4.9%) | $10.01B(-5.8%) |
Dec 2023 | $10.35B(+5.5%) | $2.46B(-22.9%) | $10.63B(+0.3%) |
Sep 2023 | - | $3.19B(+78.6%) | $10.61B(+2.3%) |
Jun 2023 | - | $1.78B(-44.2%) | $10.36B(+5.4%) |
Mar 2023 | - | $3.20B(+31.6%) | $9.83B(-0.4%) |
Dec 2022 | $9.81B(+64.5%) | $2.43B(-17.4%) | $9.87B(+11.4%) |
Sep 2022 | - | $2.95B(+134.7%) | $8.86B(+16.1%) |
Jun 2022 | - | $1.25B(-61.2%) | $7.63B(+4.9%) |
Mar 2022 | - | $3.23B(+127.2%) | $7.27B(+21.3%) |
Dec 2021 | $5.96B(+24.3%) | $1.42B(-17.2%) | $6.00B(-5.9%) |
Sep 2021 | - | $1.72B(+92.2%) | $6.38B(-1.7%) |
Jun 2021 | - | $895.00M(-54.3%) | $6.48B(-2.3%) |
Mar 2021 | - | $1.96B(+8.7%) | $6.64B(+37.0%) |
Dec 2020 | $4.80B(+61.6%) | $1.80B(-1.4%) | $4.85B(+9.2%) |
Sep 2020 | - | $1.83B(+74.3%) | $4.44B(+18.4%) |
Jun 2020 | - | $1.05B(+528.1%) | $3.75B(+3.7%) |
Mar 2020 | - | $167.00M(-88.0%) | $3.61B(+16.7%) |
Dec 2019 | $2.97B(+13.4%) | $1.39B(+22.3%) | $3.09B(-22.0%) |
Sep 2019 | - | $1.14B(+24.5%) | $3.97B(+19.2%) |
Jun 2019 | - | $914.00M(-360.4%) | $3.33B(+29.6%) |
Mar 2019 | - | -$351.00M(-115.5%) | $2.57B(-8.7%) |
Dec 2018 | $2.62B(-26.8%) | $2.27B(+354.1%) | $2.81B(+77.0%) |
Sep 2018 | - | $499.00M(+226.1%) | $1.59B(-52.9%) |
Jun 2018 | - | $153.00M(-243.0%) | $3.38B(-3.6%) |
Mar 2018 | - | -$107.00M(-110.3%) | $3.50B(-6.4%) |
Dec 2017 | $3.58B(-13.7%) | $1.04B(-54.4%) | $3.74B(-20.3%) |
Sep 2017 | - | $2.29B(+716.4%) | $4.69B(+43.9%) |
Jun 2017 | - | $280.00M(+110.5%) | $3.26B(+2.5%) |
Mar 2017 | - | $133.00M(-93.3%) | $3.18B(-25.7%) |
Dec 2016 | $4.14B(+24.7%) | $2.00B(+133.9%) | $4.29B(+48.7%) |
Sep 2016 | - | $853.00M(+322.3%) | $2.88B(-24.5%) |
Jun 2016 | - | $202.00M(-83.6%) | $3.82B(-19.0%) |
Mar 2016 | - | $1.24B(+108.6%) | $4.71B(+36.8%) |
Dec 2015 | $3.32B(-52.9%) | $592.00M(-66.9%) | $3.45B(-27.4%) |
Sep 2015 | - | $1.79B(+62.7%) | $4.75B(-3.9%) |
Jun 2015 | - | $1.10B(-3534.4%) | $4.94B(-16.9%) |
Mar 2015 | - | -$32.00M(-101.7%) | $5.95B(-17.4%) |
Dec 2014 | $7.06B(-4.6%) | $1.89B(-4.3%) | $7.20B(-7.9%) |
Sep 2014 | - | $1.98B(-6.0%) | $7.82B(+11.6%) |
Jun 2014 | - | $2.11B(+73.1%) | $7.00B(+7.5%) |
Mar 2014 | - | $1.22B(-51.5%) | $6.51B(-12.9%) |
Dec 2013 | $7.40B(+6.5%) | $2.51B(+115.2%) | $7.48B(-5.1%) |
Sep 2013 | - | $1.17B(-27.9%) | $7.88B(-2.3%) |
Jun 2013 | - | $1.62B(-25.8%) | $8.06B(+4.2%) |
Mar 2013 | - | $2.18B(-25.1%) | $7.73B(+8.9%) |
Dec 2012 | $6.95B(-11.2%) | $2.91B(+115.8%) | $7.10B(-2.3%) |
Sep 2012 | - | $1.35B(+4.5%) | $7.27B(-7.5%) |
Jun 2012 | - | $1.29B(-16.6%) | $7.86B(+4.3%) |
Mar 2012 | - | $1.55B(-49.8%) | $7.53B(-5.6%) |
Dec 2011 | $7.82B | $3.08B(+59.0%) | $7.98B(-7.2%) |
Sep 2011 | - | $1.94B(+100.7%) | $8.60B(-6.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2011 | - | $965.08M(-51.7%) | $9.15B(-17.8%) |
Mar 2011 | - | $2.00B(-46.1%) | $11.14B(+2.5%) |
Dec 2010 | $10.68B(-9.0%) | $3.70B(+49.2%) | $10.87B(-3.0%) |
Sep 2010 | - | $2.48B(-15.8%) | $11.21B(+0.4%) |
Jun 2010 | - | $2.95B(+70.5%) | $11.16B(-0.9%) |
Mar 2010 | - | $1.73B(-57.2%) | $11.26B(-4.4%) |
Dec 2009 | $11.74B(+34.3%) | $4.05B(+66.1%) | $11.78B(+10.4%) |
Sep 2009 | - | $2.44B(-20.2%) | $10.67B(+7.7%) |
Jun 2009 | - | $3.05B(+35.8%) | $9.91B(+13.0%) |
Mar 2009 | - | $2.25B(-23.5%) | $8.77B(-2.2%) |
Dec 2008 | $8.74B(+16.4%) | $2.94B(+75.7%) | $8.97B(-1.4%) |
Sep 2008 | - | $1.67B(-12.7%) | $9.09B(+3.1%) |
Jun 2008 | - | $1.92B(-21.6%) | $8.82B(+10.1%) |
Mar 2008 | - | $2.44B(-20.2%) | $8.01B(+1.8%) |
Dec 2007 | $7.51B(-2.4%) | $3.06B(+118.3%) | $7.87B(+11.4%) |
Sep 2007 | - | $1.40B(+26.9%) | $7.06B(-10.6%) |
Jun 2007 | - | $1.10B(-52.0%) | $7.90B(-9.9%) |
Mar 2007 | - | $2.30B(+2.1%) | $8.77B(+9.1%) |
Dec 2006 | $7.69B(+14.1%) | $2.25B(+0.4%) | $8.04B(+3.2%) |
Sep 2006 | - | $2.24B(+13.5%) | $7.79B(+6.4%) |
Jun 2006 | - | $1.98B(+25.8%) | $7.32B(+4.9%) |
Mar 2006 | - | $1.57B(-21.4%) | $6.98B(+0.5%) |
Dec 2005 | $6.74B(+40.0%) | $2.00B(+12.7%) | $6.95B(-0.4%) |
Sep 2005 | - | $1.77B(+8.5%) | $6.97B(+11.2%) |
Jun 2005 | - | $1.63B(+6.2%) | $6.27B(+16.6%) |
Mar 2005 | - | $1.54B(-24.0%) | $5.38B(+8.8%) |
Dec 2004 | $4.82B(+43.0%) | $2.03B(+88.9%) | $4.94B(+19.0%) |
Sep 2004 | - | $1.07B(+44.8%) | $4.15B(+6.7%) |
Jun 2004 | - | $740.49M(-32.9%) | $3.89B(+8.1%) |
Mar 2004 | - | $1.10B(-10.8%) | $3.60B(+5.1%) |
Dec 2003 | $3.37B(-30.3%) | $1.24B(+52.6%) | $3.43B(-5.1%) |
Sep 2003 | - | $810.77M(+80.2%) | $3.61B(+1.7%) |
Jun 2003 | - | $450.00M(-51.5%) | $3.55B(-9.6%) |
Mar 2003 | - | $928.67M(-34.7%) | $3.93B(-18.9%) |
Dec 2002 | $4.83B(+54.6%) | $1.42B(+89.9%) | $4.84B(+19.3%) |
Sep 2002 | - | $748.83M(-9.6%) | $4.06B(-6.8%) |
Jun 2002 | - | $828.05M(-55.1%) | $4.36B(+16.5%) |
Mar 2002 | - | $1.84B(+188.2%) | $3.74B(+19.7%) |
Dec 2001 | $3.13B(+33.8%) | $640.08M(-38.6%) | $3.13B(+108.5%) |
Sep 2001 | - | $1.04B(+391.3%) | $1.50B(-39.2%) |
Jun 2001 | - | $212.27M(-82.8%) | $2.47B(-20.9%) |
Mar 2001 | - | $1.23B(-224.7%) | $3.12B(+33.4%) |
Dec 2000 | $2.34B(+9.9%) | -$986.91M(-149.1%) | $2.34B(-29.7%) |
Sep 2000 | - | $2.01B(+133.1%) | $3.32B(+153.2%) |
Jun 2000 | - | $862.75M(+92.0%) | $1.31B(+192.0%) |
Mar 2000 | - | $449.42M | $449.42M |
Dec 1999 | $2.13B(-37.9%) | - | - |
Dec 1998 | $3.42B(+358.0%) | - | - |
Dec 1997 | $747.21M(-5.1%) | - | - |
Dec 1996 | $787.75M(+34.5%) | - | - |
Dec 1995 | $585.64M(-6.4%) | - | - |
Dec 1994 | $625.36M(-11.4%) | - | - |
Dec 1993 | $705.58M(+242.1%) | - | - |
Dec 1992 | $206.27M(-59.2%) | - | - |
Dec 1991 | $505.22M(-37.3%) | - | - |
Dec 1990 | $806.30M | - | - |
FAQ
- What is AstraZeneca PLC annual cash flow from operations?
- What is the all time high annual CFO for AstraZeneca PLC?
- What is AstraZeneca PLC annual CFO year-on-year change?
- What is AstraZeneca PLC quarterly cash flow from operations?
- What is the all time high quarterly CFO for AstraZeneca PLC?
- What is AstraZeneca PLC quarterly CFO year-on-year change?
- What is AstraZeneca PLC TTM cash flow from operations?
- What is the all time high TTM CFO for AstraZeneca PLC?
- What is AstraZeneca PLC TTM CFO year-on-year change?
What is AstraZeneca PLC annual cash flow from operations?
The current annual CFO of AZN is $11.86B
What is the all time high annual CFO for AstraZeneca PLC?
AstraZeneca PLC all-time high annual cash flow from operations is $11.86B
What is AstraZeneca PLC annual CFO year-on-year change?
Over the past year, AZN annual cash flow from operations has changed by +$1.52B (+14.65%)
What is AstraZeneca PLC quarterly cash flow from operations?
The current quarterly CFO of AZN is $3.51B
What is the all time high quarterly CFO for AstraZeneca PLC?
AstraZeneca PLC all-time high quarterly cash flow from operations is $4.05B
What is AstraZeneca PLC quarterly CFO year-on-year change?
Over the past year, AZN quarterly cash flow from operations has changed by +$311.12M (+9.73%)
What is AstraZeneca PLC TTM cash flow from operations?
The current TTM CFO of AZN is $13.72B
What is the all time high TTM CFO for AstraZeneca PLC?
AstraZeneca PLC all-time high TTM cash flow from operations is $13.72B
What is AstraZeneca PLC TTM CFO year-on-year change?
Over the past year, AZN TTM cash flow from operations has changed by +$2.29B (+20.06%)